Then we further confirmed that DJ-1, one of the differently regulated marker identified in proteomic analysis, is a novel cisplatin-resistant marker and an independent prognostic factor for locally advanced NSCLC patients. This evidence concerns the gene PARK7 and non-small cell lung carcinoma.